E. Wood, S. Low-beer, K. Bartholomew, M. Landolt, D. Oram et al., Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End, Can J Public Health, issue.2, pp.91-125, 2000.

E. Vittinghoff, S. Scheer, P. O. Malley, G. Colfax, S. D. Holmberg et al., Combination Antiretroviral Therapy and Recent Declines in AIDS Incidence and Mortality, The Journal of Infectious Diseases, vol.179, issue.3, pp.717-737, 1999.
DOI : 10.1086/314623

R. D. Moore and R. E. Chaisson, Natural history of HIV infection in the_era of combination antiretroviral therapy, AIDS, vol.13, issue.14, pp.1933-1975, 1999.
DOI : 10.1097/00002030-199910010-00017

A. Mocroft, S. Vella, T. L. Benfield, A. Chiesi, V. Miller et al., Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group, Lancet, issue.9142, pp.352-1725, 1998.

F. J. Palella, K. M. Jr, A. C. Delaney, M. O. Moorman, J. Loveless et al., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, N Engl J Med, issue.13, pp.338-853, 1998.

G. J. Dore, Y. Li, A. Mcdonald, H. Ree, J. M. Kaldor et al., Impact of Highly Active Antiretroviral Therapy on Individual AIDS-Defining Illness Incidence and Survival in Australia, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.4, pp.388-95, 2002.
DOI : 10.1097/00126334-200204010-00010

M. Egger, B. Hirschel, P. Francioli, P. Sudre, M. Wirz et al., Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study, BMJ, vol.315, issue.7117, pp.315-1194, 1997.
DOI : 10.1136/bmj.315.7117.1194

R. S. Hogg, B. Yip, C. Kully, K. J. Craib, M. V. O-'shaughnessy et al., Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens, Cmaj, issue.5, pp.160-659, 1999.

A. Meyer, F. Munoz, and . Liegeois, Effectiveness of highly active antiretroviral therapy among HIV-1 infected women WHO, Scaling up antiretroviral therapy in resource limited settings : guidelines for a public health approach The Senegalese government's highly active antiretroviral therapy initiative: an 18- month follow-up study, J Epidemiol Community Health Aids, vol.56, issue.1110, pp.153-162, 2002.

P. Farmer, F. Leandre, J. S. Mukherjee, M. Claude, P. Nevil et al., Community-based approaches to HIV treatment in resource-poor settings, The Lancet, vol.358, issue.9279, pp.358-404, 2001.
DOI : 10.1016/S0140-6736(01)05550-7

A. S. Pereira, A. D. Kashuba, S. A. Fiscus, J. E. Hall, R. R. Tidwell et al., Nucleoside Analogues Achieve High Concentrations in Seminal Plasma: Relationship between Drug Concentration and Virus Burden, The Journal of Infectious Diseases, vol.180, issue.6, pp.180-2039, 1999.
DOI : 10.1086/315149

C. E. Hart, J. L. Lennox, M. Pratt-palmore, T. C. Wright, R. F. Schinazi et al., Correlation of Human Immunodeficiency Virus Type 1 RNA Levels in Blood and the Female Genital Tract, The Journal of Infectious Diseases, vol.179, issue.4, pp.871-82, 1999.
DOI : 10.1086/314656

M. Musicco, A. Lazzarin, A. Nicolosi, M. Gasparini, P. Costigliola et al., Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.PG -1971-6, Arch Intern Med, issue.17, p.154, 1994.

. Herman, Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.PG -110-6, J Clin Microbiol, vol.37, issue.1, pp.110-116, 1999.

R. G. Newcombe, Two-sided confidence intervals for the single proportion: comparison of seven methods WHO, Basic science in HIV/AIDS : an update, pp.17-857, 1998.

J. Biryahwaho and . Whitworth, Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort, Aids, vol.15, issue.3, pp.293-302, 2001.

A. S. Fauci, G. Pantaleo, S. Stanley, and D. Weissman, Immunopathogenic Mechanisms of HIV Infection, Annals of Internal Medicine, vol.124, issue.7, pp.654-63, 1996.
DOI : 10.7326/0003-4819-124-7-199604010-00006

K. Anastos, S. J. Gange, B. Lau, B. Weiser, R. Detels et al., Association of race and gender with HIV-1 RNA levels and immunologic progression, J Acquir Immune Defic Syndr, issue.3, pp.24-218, 2000.

R. H. Lutalo, R. H. Gray-gray, M. J. Wawer, R. Brookmeyer, N. K. Sewankambo et al., Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Health, D.o., National HIV and Syphilis antenatal sero-prevalence survey in South Africa, pp.342-921, 2000.

J. Mugyenyi and . Mermin, Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance, Lancet, issue.9326, pp.360-394, 2002.

A. J. Frater, D. T. Dunn, A. J. Beardall, K. Ariyoshi, J. R. Clarke et al., Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy, AIDS, vol.16, issue.8, pp.16-1139, 2002.
DOI : 10.1097/00002030-200205240-00007

A. Attaran and J. Sachs, Defining and refining international donor support for combating the AIDS pandemic, The Lancet, vol.357, issue.9249, pp.57-61, 2001.
DOI : 10.1016/S0140-6736(00)03576-5

B. Schwartlander, J. Stover, N. Walker, L. Bollinger, J. P. Gutierrez et al., The epidemiology of human immunodeficiency virus in South Africa Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission, AIDS. Resource needs for HIVAIDS. Science Philos Trans R Soc Lond B Biol Sci Aids, vol.32, issue.3313, pp.292-2434, 1411.

C. C. Ginocchio, X. P. Wang, M. H. Kaplan, G. Mulligan, D. Witt et al., Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma, J Clin Microbiol, issue.11, pp.35-2886, 1997.

E. Wood, P. Braitstein, J. S. Montaner, M. T. Schechter, M. W. Tyndall et al., Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa, The Lancet, vol.355, issue.9221, pp.355-2095, 2000.
DOI : 10.1016/S0140-6736(00)02375-8

J. X. Velasco-hernandez, H. B. Gershengorn, and S. M. Blower, Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?, The Lancet Infectious Diseases, vol.2, issue.8, pp.487-93, 2002.
DOI : 10.1016/S1473-3099(02)00346-8

B. Leynaert, A. M. Downs, and I. De-vincenzi, Heterosexual Transmission of Human Immunodeficiency Virus: Variability of Infectivity throughout the Course of Infection, American Journal of Epidemiology, vol.148, issue.1, pp.88-96, 1998.
DOI : 10.1093/oxfordjournals.aje.a009564

J. Mugyenyi and . Mermin, Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance.PG -34-40, Lancet, issue.9326, p.360, 2002.

L. Vergne, G. Malonga-mouellet, I. Mistoul, R. Mavoungou, H. Mansaray et al., Resistance to Antiretroviral Treatment in Gabon: Need for Implementation of Guidelines on Antiretroviral Therapy Use and HIV-1 Drug Resistance Monitoring in Developing Countries, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.29, issue.2, p.29, 2002.
DOI : 10.1097/00042560-200202010-00009

C. Adje, R. Cheingsong, T. H. Roels, C. Maurice, G. Djomand et al., High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote, J Acquir Immune Defic Syndr, issue.5, p.26, 2001.

N. Z. Nyazema, S. Khoza, I. Landman, E. Sibanda, and K. Gael, Antiretrovial (ARV) drug utilisation in Harare, Cent Afr J Med, vol.46, issue.4, pp.89-93, 2000.

C. Laurent, N. Diakhate, N. F. Gueye, M. A. Toure, P. S. Sow et al., The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study, AIDS, vol.16, issue.10, p.16, 2002.
DOI : 10.1097/00002030-200207050-00008

A. J. Frater, D. T. Dunn, A. J. Beardall, K. Ariyoshi, J. R. Clarke et al., Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.PG -1139-46, Aids, issue.8, p.16, 2002.

A. D. Harries, D. S. Nyangulu, N. J. Hargreaves, O. Kaluwa, and F. M. Salaniponi, Preventing antiretroviral anarchy in sub-Saharan Africa, The Lancet, vol.358, issue.9279, pp.358-410, 2001.
DOI : 10.1016/S0140-6736(01)05551-9

H. Zhang, G. Dornadula, M. Beumont, L. Livornese, J. et al., Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.PG - 1803-9, N Engl J Med, issue.25, p.339, 1998.

. Weller, The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis.PG -219-25, Aids, issue.2, p.16, 2002.

P. L. Vernazza, L. Troiani, M. J. Flepp, R. W. Cone, J. Schock et al., Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study, p.14, 2000.

A. N. Phillips, A. C. Lepri, F. Lampe, M. Johnson, and C. A. Sabin, When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies, AIDS, vol.17, issue.13, pp.17-1863, 2003.
DOI : 10.1097/00002030-200309050-00004

E. Marseille, P. B. Hofmann, and J. G. Kahn, HIV prevention before HAART in sub-Saharan Africa, The Lancet, vol.359, issue.9320, pp.359-1851, 2002.
DOI : 10.1016/S0140-6736(02)08705-6

A. Creese, K. Floyd, A. Alban, and L. Guinness, Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence, The Lancet, vol.359, issue.9318, pp.359-1635, 2002.
DOI : 10.1016/S0140-6736(02)08595-1

M. Carael, J. Cleland, J. C. Deheneffe, B. Ferry, and R. Ingham, Sexual behaviour in developing countries, AIDS, vol.9, issue.10, pp.1171-1176, 1995.
DOI : 10.1097/00002030-199510000-00009

B. Auvert, A. Buve, B. Ferry, M. Carael, L. Morison et al., Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection, AIDS, vol.15, pp.15-15, 2001.
DOI : 10.1097/00002030-200108004-00003

. Buve, Condom use and its association with HIV/sexually transmitted diseases in four urban communities of sub-Saharan Africa, pp.71-79, 2001.

D. L. Roth, K. E. Stewart, O. J. Clay, A. Van-der-straten, E. Karita et al., Sexual practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counselling programme for men, International Journal of STD & AIDS, vol.12, issue.3, pp.12-181, 2001.
DOI : 10.1258/0956462011916992

N. H. Dukers, J. Goudsmit, J. B. De-wit, M. Prins, G. J. Weverling et al., Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection, AIDS, vol.15, issue.3, pp.15-369, 2001.
DOI : 10.1097/00002030-200102160-00010

M. H. Katz, S. K. Schwarcz, T. A. Kellogg, J. D. Klausner, J. W. Dilley et al., Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco, American Journal of Public Health, vol.92, issue.3, pp.92-388, 2002.
DOI : 10.2105/AJPH.92.3.388